secwatch / observer
8-K filed April 3, 2023, 7:59 PM ET ticker AVAI CIK 0001740797
M&A confidence high sentiment neutral materiality 0.65

AVAI BIO, INC. (AVAI): M&A transaction — Trend Innovations issues 26M shares for Avant-AI AI system and 5,000 convertible preferred for Instant Fame assets

AVAI BIO, INC.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

AVAI BIO, INC. completed an acquisition involving Treasure Drive Ltd. (closed 2023-04-03).

Action
acquisition
Counterparty
Treasure Drive Ltd.
Closing
2023-04-03
Exact text from the filing
On April 3, 2023, the Company, entered into an Asset Purchase Agreement (“Treasure APA”) with Treasure Drive Ltd. (“TD”) pursuant to which the Company agreed to acquire a technology portfolio including certain source codes and pending patent applications which have applications in a variety of areas including creating systems and methods of facilitating digital rating and secured sales of digital works as well as core virtual reality platforms known as digital auction systems, rating and secure sales via open bid auctions (“Instant Fame Assets”). At closing, in consideration of the Instant Fame Assets, the Company shall issue to TD 5,000 convertible preferred shares of the Company with a stated valued at $5,000 per share each (the “Preferred Shares”).
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

AVAI BIO, INC. underwent a change of control involving GBT Tokenize Corp. (closed 2023-04-03).

Action
change of control
Counterparty
GBT Tokenize Corp.
Closing
2023-04-03
Exact text from the filing
On April 3, 2023, Trend Innovation Holdings, Inc. (the “Company”), entered into an Asset Purchase Agreement (“APA”) along with GBT Tokenize Corp. (“Seller”), which Seller developed and owns a proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model that is working based on an innovative, unique concept which learns on its own and constantly enhances its information database with the advantage of unsupervised learning capabilities (the “System”). At closing, in consideration of acquiring the System, the Company shall issue to the Seller 26,000,000 common shares of the Company (the “Shares”).
View on SEC.gov

24 m&a transactions filed in the last 30 days. Browse all m&a transactions →

AVAI BIO, INC. filing history →

Source: SEC EDGAR
accession 0001740797-23-000022
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.